Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben Murrell

Showing results (31-40 of 119) with videos related to

Pageof 12
Sort By:
Virus Evolution|May 20, 2024
Optimized SMRT-UMI protocol produces highly accurate sequence datasets from diverse populations-Application to HIV-1 quasispeciesDylan H Westfall, Wenjie Deng, Alec Pankow, et al.
Nano Letters|March 9, 2023
A Multiparametric and High-Throughput Platform for Host-Virus Binding ScreensJan Schlegel, Bartlomiej Porebski, Luca Andronico, et al.
Journal of Virology|March 30, 2012
Deep sequencing reveals minor protease resistance mutations in patients failing a protease inhibitor regimenRandall Fisher, Gert U van Zyl, Simon A A Travers, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2023
Optimized SMRT-UMI protocol produces highly accurate sequence datasets from diverse populations - application to HIV-1 quasispeciesDylan H Westfall, Wenjie Deng, Alec Pankow, et al.
Frontiers in Virology (Lausanne, Switzerland)|April 12, 2023
Frequent use of IGHV3-30-3 in SARS-CoV-2 neutralizing antibody responsesPradeepa Pushparaj, Andrea Nicoletto, Xaquin Castro Dopico, et al.
Nature Communications|February 27, 2023
Phenotypic characterization of single CD4+ T cells harboring genetically intact and inducible HIV genomesCaroline Dufour, Corentin Richard, Marion Pardons, et al.
Frontiers in Bioengineering and Biotechnology|December 29, 2022
Silver nanoparticles with excellent biocompatibility block pseudotyped SARS-CoV-2 in the presence of lung surfactantGovind Gupta, Bejan Hamawandi, Daniel J Sheward, et al.
The Lancet. Infectious Diseases|September 30, 2023
Sensitivity of the SARS-CoV-2 BA.2.86 variant to prevailing neutralising antibody responsesDaniel J Sheward, Yiqiu Yang, Michelle Westerberg, et al.
Plos Computational Biology|September 26, 2014
IDEPI: rapid prediction of HIV-1 antibody epitopes and other phenotypic features from sequence data using a flexible machine learning platformN Lance Hepler, Konrad Scheffler, Steven Weaver, et al.
Ebiomedicine|January 10, 2021
Adjuvanted SARS-CoV-2 spike protein elicits neutralizing antibodies and CD4 T cell responses after a single immunization in miceKatharina Wørzner, Daniel J Sheward, Signe Tandrup Schmidt, et al.
Pageof 12

Showing results (31-40 of 119) with videos related to

Sort By:
Pageof 12
Virus Evolution|May 20, 2024
Optimized SMRT-UMI protocol produces highly accurate sequence datasets from diverse populations-Application to HIV-1 quasispeciesDylan H Westfall, Wenjie Deng, Alec Pankow, et al.
Nano Letters|March 9, 2023
A Multiparametric and High-Throughput Platform for Host-Virus Binding ScreensJan Schlegel, Bartlomiej Porebski, Luca Andronico, et al.
Journal of Virology|March 30, 2012
Deep sequencing reveals minor protease resistance mutations in patients failing a protease inhibitor regimenRandall Fisher, Gert U van Zyl, Simon A A Travers, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2023
Optimized SMRT-UMI protocol produces highly accurate sequence datasets from diverse populations - application to HIV-1 quasispeciesDylan H Westfall, Wenjie Deng, Alec Pankow, et al.
Frontiers in Virology (Lausanne, Switzerland)|April 12, 2023
Frequent use of IGHV3-30-3 in SARS-CoV-2 neutralizing antibody responsesPradeepa Pushparaj, Andrea Nicoletto, Xaquin Castro Dopico, et al.
Nature Communications|February 27, 2023
Phenotypic characterization of single CD4+ T cells harboring genetically intact and inducible HIV genomesCaroline Dufour, Corentin Richard, Marion Pardons, et al.
Frontiers in Bioengineering and Biotechnology|December 29, 2022
Silver nanoparticles with excellent biocompatibility block pseudotyped SARS-CoV-2 in the presence of lung surfactantGovind Gupta, Bejan Hamawandi, Daniel J Sheward, et al.
The Lancet. Infectious Diseases|September 30, 2023
Sensitivity of the SARS-CoV-2 BA.2.86 variant to prevailing neutralising antibody responsesDaniel J Sheward, Yiqiu Yang, Michelle Westerberg, et al.
Plos Computational Biology|September 26, 2014
IDEPI: rapid prediction of HIV-1 antibody epitopes and other phenotypic features from sequence data using a flexible machine learning platformN Lance Hepler, Konrad Scheffler, Steven Weaver, et al.
Ebiomedicine|January 10, 2021
Adjuvanted SARS-CoV-2 spike protein elicits neutralizing antibodies and CD4 T cell responses after a single immunization in miceKatharina Wørzner, Daniel J Sheward, Signe Tandrup Schmidt, et al.
Pageof 12